Grimes & Company, Inc. Novo Nordisk A S Transaction History

Grimes & Company, Inc.

$3.22 Billion
Q1 2024

A detailed history of Grimes & Company, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Grimes & Company, Inc. holds 105,684 shares of NVO stock, worth $14.7 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

105,684

Previous 102,770 2.84%

Holding current value

$14.7 Million

Previous $10.6 Million 27.64%

% of portfolio

0.42%

Previous 0.36%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$102.11 - $135.92 $297,548 - $396,070	2,914 Added 2.84%	105,684 $13.6 Million
Q4 2023 Jan 24, 2024	BUY	$87.78 - $105.45 $165,816 - $199,195	1,889 Added 1.87%	102,770 $10.6 Million
Q3 2023 Oct 19, 2023	BUY	$90.94 - $199.54 $4.31 Million - $9.46 Million	47,395 Added 88.61%	100,881 $9.17 Million
Q2 2023 Jul 19, 2023	BUY	$155.98 - $172.65 $38,995 - $43,162	250 Added 0.47%	53,486 $8.66 Million
Q1 2023 Apr 20, 2023	SELL	$132.34 - $159.14 $3.5 Million - $4.21 Million	-26,426 Reduced 33.17%	53,236 $8.47 Million

Q4 2022 Jan 25, 2023	BUY	$102.55 - $135.33 $119,983 - $158,336	1,170 Added 1.49%	79,662 $0
Q3 2022 Oct 28, 2022	SELL	$95.28 - $116.93 $147,969 - $181,592	-1,553 Reduced 1.94%	78,492 $7.82 Million
Q2 2022 Jul 22, 2022	SELL	$103.24 - $121.81 $3.09 Million - $3.65 Million	-29,925 Reduced 27.21%	80,045 $8.92 Million
Q1 2022 May 06, 2022	SELL	$93.1 - $112.54 $6.32 Million - $7.64 Million	-67,853 Reduced 38.16%	109,970 $12.2 Million
Q4 2021 Feb 01, 2022	SELL	$95.88 - $117.08 $59,829 - $73,057	-624 Reduced 0.35%	177,823 $19.9 Million
Q3 2021 Nov 08, 2021	SELL	$84.42 - $106.62 $313,367 - $395,773	-3,712 Reduced 2.04%	178,447 $17.1 Million
Q2 2021 Aug 04, 2021	BUY	$67.66 - $84.76 $48,309 - $60,518	714 Added 0.39%	182,159 $15.3 Million
Q1 2021 May 12, 2021	BUY	$67.06 - $75.82 $1.37 Million - $1.55 Million	20,418 Added 12.68%	181,445 $12.2 Million
Q4 2020 Feb 02, 2021	BUY	$63.89 - $73.8 $504,794 - $583,093	7,901 Added 5.16%	161,027 $11.2 Million
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $2.89 Million - $3.18 Million	-45,350 Reduced 22.85%	153,126 $10.6 Million
Q2 2020 Jul 31, 2020	SELL	$58.54 - $67.94 $260,444 - $302,265	-4,449 Reduced 2.19%	198,476 $13 Million
Q1 2020 May 05, 2020	SELL	$49.46 - $64.78 $305,761 - $400,469	-6,182 Reduced 2.96%	202,925 $12.2 Million
Q4 2019 Feb 05, 2020	SELL	$49.86 - $58.26 $241,471 - $282,153	-4,843 Reduced 2.26%	209,107 $12.1 Million
Q3 2019 Nov 05, 2019	BUY	$47.54 - $53.43 $75,350 - $84,686	1,585 Added 0.75%	213,950 $11.1 Million
Q2 2019 Jul 30, 2019	BUY	$46.79 - $52.47 $126,941 - $142,351	2,713 Added 1.29%	212,365 $10.8 Million
Q1 2019 May 02, 2019	BUY	$46.36 - $52.63 $204,354 - $231,993	4,408 Added 2.15%	209,652 $11 Million
Q4 2018 Feb 01, 2019	BUY	$41.54 - $47.25 $23,387 - $26,601	563 Added 0.28%	205,244 $9.46 Million
Q3 2018 Nov 09, 2018	BUY	$46.76 - $51.24 $379,691 - $416,068	8,120 Added 4.13%	204,681 $9.65 Million
Q2 2018 Aug 10, 2018	SELL	$44.29 - $50.42 $88,004 - $100,184	-1,987 Reduced 1.0%	196,561 $9.07 Million
Q1 2018 May 07, 2018	SELL	$48.49 - $58.14 $7,418 - $8,895	-153 Reduced 0.08%	198,548 $9.78 Million
Q4 2017 Feb 05, 2018	SELL	$47.53 - $53.73 $194,160 - $219,487	-4,085 Reduced 2.01%	198,701 $10.7 Million
Q3 2017 Nov 03, 2017	BUY	$41.15 - $49.22 $8.34 Million - $9.98 Million	202,786	202,786 $9.76 Million

Others Institutions Holding NVO

# of Institutions

1,859

Shares Held

310M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $313B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Account

Grimes & Company, Inc. Novo Nordisk A S Transaction History